Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for oral premalignant lesions
2009-014833-26Phase 2Completed
- Sponsor
- European Institute of Oncology
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in oral premalignancies comparing Pioglitazone with Placebo (2 arms). Primary endpoint: Percentage of clinical or histological responses. Started Nov 2009; status: completed.
02
Drugs
pioglitazone
03
Conditions
oral premalignancies
Beyond the preview
Go deeper on 2009-014833-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014833-26.